Research News and Research

RSS

Scientific update conference on Lyme and Tick-Borne Diseases

Lyme disease is a growing threat in the U.S., with numbers that continue to rise despite increased awareness about the disease. "Little is being done to stop the spread of Lyme disease and to help those who are suffering from chronic Lyme," says Pat Smith, president of the all-volunteer national Lyme Disease Association, which funds research, educates the public, and provides scientific conferences for doctors.

20 Sep 2010

APAF selects AB SCIEX TripleTOF 5600 System to help advance proteomics research

AB SCIEX, a global leader in life science analytical technologies, today announced that the Australian Proteome Analysis Facility has chosen the AB SCIEX TripleTOF 5600 System to help advance proteomics research by significantly expanding proteome coverage. The TripleTOF 5600 System is the life science industry's fastest and most sensitive high-resolution mass spectrometer for high-performance qualitative and quantitative analysis.

20 Sep 2010

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.

20 Sep 2010

ICF International awarded re-compete contract to provide IT, scientific support services to NCTR

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a $31.8 million re-compete contract by the U.S. Food and Drug Administration to provide information technology and scientific support services to the National Center for Toxicological Research.

20 Sep 2010

Hatch Medical signs agreement with Majid Shano to broker super-elastic orthopedic stapling technology

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has recently entered into an agreement with Majid Shano MB, B.CH., (Munich, Germany) to broker his patented, super-elastic orthopedic stapling technology.

20 Sep 2010

Chronix Biomedical completes Series E financing

Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.

20 Sep 2010

First Edition: September 20, 2010

Today's headlines include news about the political positioning of both Democrats and Republicans on health reform, the mid-term elections and GOP plans to repeal and replace.

20 Sep 2010

PAREXEL and Eli Lilly enter strategic functional service provider relationship

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the establishment of a strategic functional service provider relationship with Eli Lilly and Company, a global pharmaceutical company, to support study start-up and site monitoring of clinical trials throughout the Asia/Pacific region. PAREXEL will assist Lilly in bringing greater efficiencies to its clinical research studies to help meet Lilly's development and commercialization goals.

From Parexel 20 Sep 2010

Myrexis releases MPC-9528 cancer metabolism inhibitor preclinical study results

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.

20 Sep 2010

High-intensity exercise video game to improve health of middle aged men

Sedentary middle-aged men on Teesside in the North East of England could soon be using a high-intensity exercise video game to improve their health. For researchers at Teesside University have developed an alternative to the Nintendo Wii which doesn't allow users to cheat. Now they plan to put it to the test by getting middle-aged members of workingmen's clubs to take part in 'virtual' boxing matches with a computer-generated opponent.

20 Sep 2010

Environmental factors are cause of subarachnoid haemorrhage in most cases

The Nordic twin study investigating the heritability of subarachnoid haemorrhage (SAH) suggests that the role of genetic factors underlying the development of SAH is less than previously believed.

20 Sep 2010

Lisofylline drug effective for Type 2 diabetes

Australian scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes.

20 Sep 2010

Hain Celestial launches Earth's Best, Zhi Ling Tong organic infant products in China

The Hain Celestial Group, Inc.,a leading natural and organic products company providing consumers with A Healthy Way of Life, today announced the launch of its co-branded Earth's Best and Zhi Ling Tong organic infant formula in China through its Hutchison Hain Organic Holdings Limited ("Hutchison Hain Organic") joint venture.

20 Sep 2010

Cellectis bioresearch, Helix Biocon collaborate to promote cGPS service in India

Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis and Helix BioService & Consultants Pvt Ltd (Helix Biocon), today announced that they will join forces for the promotion of Cellectis bioresearch's meganuclease-based products and services in India.

20 Sep 2010

Oxygen Biotherapeutics announces CRADA Agreement amendment

Oxygen Biotherapeutics, Inc. today announced it has amended an existing Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Center (NMRC) to include preclinical trials using swine models to assess the safety and efficacy of Oxygen Biotherapeutics' proprietary Oxycyte perfluorocarbon emulsion (PFCE) for spinal cord injury (SCI) due to decompression sickness (DCS), and for hemorrhagic shock.

20 Sep 2010

URB937 drug boosts natural painkiller level: Study

A new study has shown how a novel compound boosts levels of a natural painkiller at the site of an injury. The ground-breaking study published today in Nature Neuroscience shows how the potential drug URB937 acts in peripheral tissue and may have the potential to relieve pain without the side effects associated with many current painkillers that act centrally on the nervous system.

20 Sep 2010

Manganese in water can harm children’s IQ: Study

A team of researchers led by Maryse Bouchard, adjunct professor at the Center for Interdisciplinary Research in Biology, Health, Environment and Society (CINBIOSE) of the Universit du Qu-bec Montr-al and a researcher at Sainte Justine University Hospital, and Donna Mergler, professor emerita in the Department of Biological Sciences and a member of CINBIOSE, recently completed a study showing that children exposed to high concentrations of manganese in drinking water performed worse on tests of intellectual functioning than children with lower exposures.

20 Sep 2010

H1N1 influenza increases neurological complications in children: Study

A recent study by researchers at the University of Utah determined that the 2009 pandemic influenza A (H1N1) caused a higher rate of neurological complications in children than the seasonal flu. The most common complications observed were seizures and encephalopathy.

20 Sep 2010

Adenovirus exposure may cause obesity in children: Study

The emerging idea that obesity may have an infectious origin gets new support in a cross-sectional study by University of California, San Diego School of Medicine researchers who found that children exposed to a particular strain of adenovirus were significantly more likely to be obese.

20 Sep 2010

Gene deletion may make you smarter: Study

A new study has shown that switching off a single gene in mice unlocks a part of their brain that is otherwise inactive, boosting learning and memory. Considering the fact that humans have a similar gene, this sparks hope for many especially those who suffer from dementia and Alzheimer’s.

20 Sep 2010